We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Self-Medicating with Herbal Cannabis Leads to Poor Mental Health

By HospiMedica International staff writers
Posted on 03 Jul 2012
A new study suggests that fibromyalgia (FM) patients that use marijuana for medicinal relief from symptomatic widespread pain, fatigue, and insomnia suffer from poorer mental health.

Researchers at McGill University Health Center (MUHC; Montreal, Canada) documented self-reported cannabinoid use in 457 FM patients. More...
FM diagnosis was validated, and associations and trends of self-medicating with medical marijuana or Cannabis, prescription cannabinoids, or both, were investigated. Patient pain levels were measured using the visual analog scale (VAS), functional ability was assessed with the Fibromyalgia Impact Questionnaire (FIQ), and a psychologist evaluated all FM participants for prior or current psychiatric conditions according to the Diagnostics and Statistical Manual of Mental Disorder (DSM-IV).

After FM diagnosis was confirmed in 302 participants, the other 155 patients were assigned another primary diagnosis (non-FM group), as controls. The researchers determined that 13% of all 457 participants used cannabinoids, with 80% using herbal Cannabis or marijuana; one third of all males used cannabinoids. Analysis found that 24% of cannabinoid users used prescription cannabinoids such as nabilone and dronabinol, and 3% were both herbal Cannabis and prescription cannabinoid users. Those smoking marijuana consumed up to 6 grams, with 72% reporting use of one gram or less per day.

The researchers determined that herbal Cannabis use was associated with unstable mental illness, opioid drug-seeking behavior, and male gender at 36%, 17%, and 26%, respectively compared to 23 %, 4%, and 7% for nonusers. A 77% unemployment rate was identified in herbal marijuana users, which the researchers believe may be due to ineffective pain control to improve functionality or a more serious functional disability. The study was published in the June 2012 issue of Arthritis Care & Research.

“While self-medicating with cannabinoids may provide some pain relief to FM patients, we caution against general use of illicit drugs until health and psychosocial issues risks are confirmed,” said lead author Prof. Mary-Ann Fitzcharles, MD. “Physicians should be alert to potential negative mental health issues in FM patients using illicit drugs for medical purposes. Some herbal Cannabis users may be dishonestly using a FM diagnosis to justify self-medicating with illegal drugs.”

Fibromyalgia is a common syndrome of chronic widespread soft-tissue pain accompanied by weakness, fatigue, and sleep disturbances; the cause is unknown, but FM is often seen as a rheumatic condition causing joint and soft tissue pain.

Related Links:

McGill University Health Center



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.